Hernando Salcedo was diagnosed with Stage III pancreatic cancer after mild symptoms. Chemotherapy made him feel worse than ...

A new pancreatic cancer treatment targeting the KRAS gene mutation represents a major breakthrough, offering the first ...

New KRAS-targeting drug for metastatic pancreatic cancer nearly doubles second-line survival; expert explains impact, side effects, next trials.

The drug will be used in conjunction with other treatments that yield results.

Researchers from the University of Minnesota Medical School have identified why pancreatic cancer is difficult for the immune ...

A newly identified inflammatory signaling target may help weaken the protective environment surrounding pancreatic tumors and ...

Russ Reed finally got his cancer drug, but others mired in red tape. “There are a lot of people who are going to die ...

Cancer immunotherapies have transformed treatment for many cancers, but pancreatic cancer remains especially difficult to ...

A new drug is doubling survival time for pancreatic cancer patients. Daraxonrasib, the drug being taken by former Sen. Ben ...

Revolution Medicines' application for a drug to treat metastatic pancreatic cancer was accepted for review by the Food and Drug Administration.

The fight against deadly pancreatic cancer took a positive turn this spring with a study finding a new drug can help patients ...